(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ANTICORPOS ANTI-IL-36R

ArquivadaInvention PatentPCT · CN2022127898

Application data

Invention Patent ANTICORPOS ANTI-IL-36R de INMAGENE PTE. LTD. — IPC A61K 35/17
Invention Patent ANTICORPOS ANTI-IL-36R de INMAGENE PTE. LTD. — IPC A61K 35/17. Drawing published by the INPI in the Industrial Property Gazette.

Number

112024008196

Type

Invention Patent

Filing

10/27/2022

Publication

04/08/2025

PCT

CN2022127898

Progress at the INPI

  1. Filing10/27/22
  2. Publication04/08/25
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 10/27/2022 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 01/21/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

INMAGENE PTE. LTD.

SG

Inventors

C. G. (pessoa física)

CN

L. F. (pessoa física)

CN

P. F. (pessoa física)

CN

Q. S. (pessoa física)

CN

R. L. (pessoa física)

CN

Z. X. (pessoa física)

CN

Technical data

Priority claims

CN

PCT/CN2021/127544 · 10/29/2021

CN

PCT/CN2022/118446 · 09/13/2022

Abstract

ANTICORPOS ANTI-IL-36R. A presente invenção refere-se a anticorpos anti-IL-36R ou fragmentos de ligação ao antígeno dos mesmos, polinucleotídeos isolados que codificam os mesmos, composições farmacêuticas que compreendem os mesmos e os usos dos mesmos.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

01/21/2026

RPI 2872

Arquivamento - Art. 33 da LPI

#11.1

11/04/2025

RPI 2861

Notificação de entrada na fase nacional - PCT

#1.3

04/08/2025

RPI 2831

Alteração de dados cadastrais

#1.1

05/07/2024

RPI 2783

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.